SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 6.9% Stake in Generation Bio
Beneficial Ownership Report
FMR LLC and its Chairman and CEO, Abigail P. Johnson, have reported a beneficial ownership of 6.9% of Generation Bio's common stock as of December 31, 2024.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 4,626,045 shares of GENERATION BIO common stock.
- This ownership represents 6.9% of the total outstanding common stock of GENERATION BIO.
- FMR LLC holds sole voting power over 4,619,336 shares and sole dispositive power over 4,626,045 shares.
- Abigail P. Johnson holds sole dispositive power over 4,626,045 shares.
- This filing is an Amendment No. 6 to Schedule 13G, indicating a continuation or update of previously reported beneficial ownership.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing disclosing beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment regarding the issuer's performance or prospects.
Positives
- A significant stake (6.9%) held by a major institutional investor like FMR LLC and its leadership may signal confidence in GENERATION BIO's long-term prospects.
- The filing explicitly states that the shares are held in the ordinary course of business, suggesting a passive investment rather than an activist intent to influence control.
Future Outlook
NA
Industry Context
This filing reflects a common practice where large asset management firms like FMR LLC (Fidelity) acquire significant, passive stakes in publicly traded companies, including those in the biotechnology sector like GENERATION BIO. Such investments are part of their portfolio management strategies, often reflecting a belief in the long-term growth potential of the underlying company or sector.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Governance Structure (FMR LLC) | Members of the Johnson family, including Abigail P. Johnson, are predominant owners of Series B voting common shares of FMR LLC (representing 49% of voting power) and have a shareholders' voting agreement to vote in accordance with the majority vote of Series B shares, potentially forming a controlling group with respect to FMR LLC. | Not specified for the agreement itself, but powers of attorney are effective January 3, 2023, and January 26, 2023. | This clarifies the internal control structure of FMR LLC, the reporting entity, rather than GENERATION BIO. It details how FMR LLC's voting power is managed internally. |
Stakeholder Impact
- Shareholders: The disclosure of a significant stake by a reputable institutional investor like FMR LLC could be viewed positively, potentially indicating institutional confidence in GENERATION BIO.
Key Dates
| Date | Description |
|---|---|
| January 3, 2023 | Effective date of Power of Attorney for FMR LLC and its direct and indirect subsidiaries. |
| January 26, 2023 | Effective date of Power of Attorney for Abigail P. Johnson. |
| December 31, 2024 | Date of event which requires the filing of this statement. |
| February 11, 2025 | Date of filing of this Schedule 13G Amendment No. 6. |
Keywords
Generation Bio, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, common stock, institutional investor, SEC filing, biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.